Sex differences in the effects of 17β-estradiol on vascular adrenergic responses

European Journal of Pharmacology

Volumn 314, Issue 3, 1996, Pages 339-345

  García Villalón, Angel L ^a   Buchholz, John N ^b   Krause, Diana N ^c   Duckles, Sue P ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenergic nerve stimulation; Gonadectomy; Noradrenaline release; Rat; Tail artery

Indexed keywords

ESTRADIOL; NORADRENALIN;

ADRENERGIC NERVE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GONADECTOMY; IN VITRO STUDY; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; TAIL ARTERY; VASOCONSTRICTION;

ANIMALS; ARTERIES; ELECTRIC STIMULATION; ESTRADIOL; FEMALE; MALE; MEMBRANE POTENTIALS; NOREPINEPHRINE; ORCHIECTOMY; OVARIECTOMY; OVARY; POTASSIUM; RATS; RATS, INBRED F344; SEX CHARACTERISTICS; SYMPATHETIC NERVOUS SYSTEM; TESTIS; VASOCONSTRICTION;

EID: 0030608361     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00565-1     Document Type: Article

References (19)

1. Altura, B.M., 1975, Sex and estrogens and responsiveness of terminal arterioles to neurohypophyseal hormones and catecholamines, J. Pharmacol. Exp. Ther. 193, 403.
2. Brown, T.J., R.B. Hochberg, J.E. Zielinski and N.J. MacLusky, 1988, Regional sex differences in cell nuclear estrogen-binding capacity in the rat hypothalamus and preoptic area, Endocrinology 123, 1761.
3. Caplan, L.R., P.B. Gorelick and D.B. Hier, 1986, Race, sex, and occlusive cerebrovascular disease. Stroke 17, 648.
4. Cheng, D.Y. and C.A. Gruetter, 1992. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta, Eur. J. Pharmacol. 215, 171.
5. Colucci, W.S., M.A. Gimbrone, Jr., M.K. McLaughlin, W. Halpern and R.W. Alexander, 1982, Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen treated male rats, Circ. Res. 50, 805.
6. Dicken, C., 1978, Sex roles, smoking and smoking cessation, J. Health Soc. Behav. 19, 324.
7. Gisclard, V., N.A. Flavahan and P.M. Vanhoutte, 1987, Alpha adrenergic responses of blood vessels of rabbits after ovariectomy and administration of 17β-estradiol, J. Pharmacol, Exp. Ther. 240, 466.
8. Guyton, A.C. and J.E. Hall, 1995, Reproductive and hormonal functions of the male (and the pineal gland), in: Textbook of Medical Physiology (W.B. Saunders, Philadelphia) p. 1003.
9. Jiang, C., P.M. Sarrel, D.C. Lindsay, P.A. Poole-Wilson and P. Collins, 1991, Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro, Br. J. Pharmacol. 104, 1033.
10. Lerner, D.J. and W.B. Kannel, 1986, Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow up of the Framingham population, Am. Heart J. 111, 383.
11. Li, L. and S.P. Duckles, 1994, Influence of gender on vascular reactivity in the rat, J. Pharmacol. Exp. Ther. 268, 1426.
12. McNeill, A.M., S.P. Duckles and D.N. Krause, 1996. Relaxant effects of 17β-estradiol in the rat tail artery are greater in females than in males, Eur. J. Pharmacol. 308, 305.
13. Miller, V.M. and P.M. Vanhoutte, 1990, 17β-estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta, Am. J. Physiol. 258, R1502.
14. Shan, J., L.M. Resnick, Q.Y. Liu, M. Barbagallo and P.K. Pang, 1994, Vascular effects of 17β-estradiol in male Sprague-Dawley rats, Am. J. Physiol. 266, H967.
15. Stallone, J.N., 1994, Sex differences in nitric oxide-mediated attenuation of vascular reactivity to vasopressin are abolished by gonadectomy, Eur. J. Pharmacol. 259, 273.
16. Stallone, J.N., J.T. Crofton and L. Share, 1991, Sexual dimorphism in vasopressin-induced contraction of rat aorta, Am. J. Physiol. 260, H453.
17. Stumpf, W.E., 1990, Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralcorticoids, and soltriol (vitamin D) on central nervous regulatory and peripheral systems, Experientia 46, 13.
18. + and U-46619, J. Cardiovasc. Pharmacol. 25, 200.
19. Ca channels through a cGMP-dependent mechanism, Circ. Res. 77, 936.